Masimo Corporation (MASI)
NASDAQ: MASI · Real-Time Price · USD
141.68
-0.58 (-0.41%)
Dec 5, 2025, 4:00 PM EST - Market closed
Masimo Employees
Masimo had 3,600 employees as of December 28, 2024. The number of employees decreased by 200 or -5.26% compared to the previous year.
Employees
3,600
Change (1Y)
-200
Growth (1Y)
-5.26%
Revenue / Employee
$606,111
Profits / Employee
-$158,167
Market Cap
7.61B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 3,600 | -200 | -5.26% |
| Dec 30, 2023 | 3,800 | -200 | -5.00% |
| Dec 31, 2022 | 4,000 | 1,800 | 81.82% |
| Dec 31, 2021 | 2,200 | 200 | 10.00% |
| Dec 31, 2020 | 2,000 | 400 | 25.00% |
| Dec 28, 2019 | 1,600 | 100 | 6.67% |
| Dec 29, 2018 | 1,500 | 100 | 7.14% |
| Dec 30, 2017 | 1,400 | 157 | 12.63% |
| Dec 31, 2016 | 1,243 | -57 | -4.38% |
| Dec 31, 2015 | 1,300 | 100 | 8.33% |
| Dec 31, 2014 | 1,200 | -1,939 | -61.77% |
| Dec 28, 2013 | 3,139 | 273 | 9.53% |
| Dec 29, 2012 | 2,866 | 318 | 12.48% |
| Jan 1, 2011 | 2,548 | 151 | 6.30% |
| Dec 31, 2009 | 2,397 | 198 | 9.00% |
| Dec 31, 2009 | 2,199 | 460 | 26.45% |
| Dec 31, 2008 | 1,739 | 391 | 29.01% |
| Dec 29, 2007 | 1,348 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MASI News
- 19 hours ago - HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 1 day ago - Masimo Pitches 2028 Plan With 30% Operating Margins - Benzinga
- 2 days ago - Masimo Corporation (MASI) Analyst/Investor Day Transcript - Seeking Alpha
- 2 days ago - Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth - Business Wire
- 18 days ago - Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case - PRNewsWire
- 18 days ago - DRC Congratulates Knobbe Martens on its $634 Million Win for Masimo - GlobeNewsWire
- 19 days ago - 4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares - The Motley Fool
- 20 days ago - Jury says Apple owes Masimo $634M for patent infringement - TechCrunch